Magnetic Resonance Imaging Evaluation of Inner Ear Pathology Using Intra-Tympanic Contrast Agent
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This is a pilot study of patients with clinical symptoms of Ménière's disease using injection
of diluted magnetic resonance imaging (MRI) contrast agent into the ear to evaluate inner ear
structures.
The goal is to reproduce imaging findings described by non-United States (US) institutions,
improve on image quality with decreased scan time and evaluate the dynamics of the contrast
movement into the inner ear structures.